Literature DB >> 20449837

Fully synthetic vaccines consisting of tumor-associated MUC1 glycopeptides and a lipopeptide ligand of the Toll-like receptor 2.

Anton Kaiser1, Nikola Gaidzik, Torsten Becker, Clara Menge, Kai Groh, Hui Cai, Yan-Mei Li, Bastian Gerlitzki, Edgar Schmitt, Horst Kunz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20449837     DOI： 10.1002/anie.201000462

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  22 in total

Review 1.  Progress in the synthesis and biological evaluation of lipid A and its derivatives.

Authors:  Jian Gao; Zhongwu Guo
Journal:  Med Res Rev       Date:  2017-06-16       Impact factor: 12.944

2.  Synthesis and Immunological Evaluation of a Multicomponent Cancer Vaccine Candidate Containing a Long MUC1 Glycopeptide.

Authors:  Nitin T Supekar; Vani Lakshminarayanan; Chantelle J Capicciotti; Anju Sirohiwal; Cathy S Madsen; Margreet A Wolfert; Peter A Cohen; Sandra J Gendler; Geert-Jan Boons
Journal:  Chembiochem       Date:  2017-11-30       Impact factor: 3.164

Review 3.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

4.  Significance of Proline Residue on Short Mucin Peptide Interactions with Mouse MUC1 Monoclonal Antibody Studied by Saturation Transfer Difference NMR Spectroscopy.

Authors:  Cheng Her; William M Westler; Thao Yang
Journal:  JSM Chem       Date:  2013-10-17

5.  Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide.

Authors:  Pamela Thompson; Vani Lakshminarayanan; Nitin T Supekar; Judy M Bradley; Peter A Cohen; Margreet A Wolfert; Sandra J Gendler; Geert-Jan Boons
Journal:  Chem Commun (Camb)       Date:  2015-05-29       Impact factor: 6.222

6.  Recent Development in Carbohydrate Based Anti-cancer Vaccines.

Authors:  Zhaojun Yin; Xuefei Huang
Journal:  J Carbohydr Chem       Date:  2012-02-29       Impact factor: 1.667

7.  Precise immunological evaluation rationalizes the design of a self-adjuvanting vaccine composed of glycan antigen, TLR1/2 ligand, and T-helper cell epitope.

Authors:  Tsung-Che Chang; Yoshiyuki Manabe; Keita Ito; Ryuku Yamamoto; Kazuya Kabayama; Shino Ohshima; Yoshie Kametani; Yukari Fujimoto; Chun-Cheng Lin; Koichi Fukase
Journal:  RSC Adv       Date:  2022-06-29       Impact factor: 4.036

8.  Synthesis and evaluation of monophosphoryl lipid A derivatives as fully synthetic self-adjuvanting glycoconjugate cancer vaccine carriers.

Authors:  Zhifang Zhou; Mohabul Mondal; Guochao Liao; Zhongwu Guo
Journal:  Org Biomol Chem       Date:  2014-04-14       Impact factor: 3.876

Review 9.  Strategy for Designing a Synthetic Tumor Vaccine: Multi-Component, Multivalency and Antigen Modification.

Authors:  Zhi-Hua Huang; Zhan-Yi Sun; Yue Gao; Pu-Guang Chen; Yan-Fang Liu; Yong-Xiang Chen; Yan-Mei Li
Journal:  Vaccines (Basel)       Date:  2014-07-15

10.  Natural and Induced Humoral Responses to MUC1.

Authors:  Silvia Von Mensdorff-Pouilly; Maria Moreno; René H M Verheijen
Journal:  Cancers (Basel)       Date:  2011-07-29       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.